Archive for the ‘Cypress Biosciences Inc’ Category

Cypress Biosciences Inc

September 7th, 2010 | Posted in Cypress Biosciences Inc

Cypress Biosciences Inc., has announced that it has licensed Alexa Pharmacrutical’s “Staccato” nicotine technology, which is a nicotine inhaler designed to help people quit smoking. Cypress will pay Alexza $5-million upfront to acquire the worldwide license for the Staccato nicotine technology.